BIA
String of appointments to BIA Board
October 15, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, appointments
The BioIndustry Association has appointed Kevin Cox, Donna Hackett, Jane Osbourn, Stephen Taylor, Patrick Verheyen and Tim Watts to its …
New drug pricing plans will ‘damage UK biotech’
August 16, 2013Research and Development, Sales and Marketing BIA, Hunt, NHS, VBP, bates, biotech
The BioIndustry Association is warning that the government’s new drug pricing scheme could put future investment in the UK’s biotech …
UK life sciences gains £93 million backing
July 31, 2013Research and Development, Sales and Marketing BIA, DMD, life sciences
The UK life sciences sector has been given a new £93.2 million package of support by the government to help …
Pharma applauds government strategy
December 11, 2012Sales and Marketing ABPI, BIA, Cameron, Willetts
The ABPI and BioIndustry Association (BIA) have both welcomed the government’s update on its Strategy for UK Life Sciences, launched …
BIA welcomes appointment of UK MEP
October 12, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Glenis Willmott
The BioIndustry Association (BIA) has said it welcomes the appointment of UK MEP Glenis Willmott as the rapporteur for the …
Appointments and moves at the BIA
October 5, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, BioIndustry Association
The BioIndustry Association (BIA) has appointed Harren Jhoti and Will West to its Board of directors at its Annual General …
Steve Bates appointed chief executive of the BioIndustry Association
June 25, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Genzyme, Steve Bates
The BioIndustry Association (BIA) has appointed Steve Bates as its chief executive. Bates has worked both in biotech and the …
Life sciences to benefit from new UK budget plans
March 21, 2012Sales and Marketing ABPI, BIA, Budget, life sciences, tax
The UK life sciences industry will benefit from a cut in corporation tax and additional funding for academic research. The …
Glyn Edwards appointed interim chief executive of the BioIndustry Association
November 24, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Glyn Edwards
The BioIndustry Association (BIA) has appointed Glyn Edwards as its interim chief executive effective immediately. Edwards was previously chief executive …
ABPI and BIA move in together
May 16, 2011Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA
The UK’s pharma industry association the ABPI and its biotech equivalent the BIA are jointly relocating to new London offices. …
Biotech lobbies for further UK tax breaks
March 17, 2011Research and Development BIA, R&D tax credits, biotech
Biotech companies are calling on Chancellor George Osborne to provide extra incentives for research in his forthcoming Budget. The budget …
New agreement seeks to speed up UK research
February 25, 2011Research and Development BIA, Industry Collaborative Research Agreement, MRC, Medical Research Council, National Institute for Health Research, Office for Clinical Research Infrastructure, UK research, clinical research, mICRA
The government has revised the research contracting process in a bid to streamline research between pharma and biotech companies, universities …
UK trade associations form new life sciences lobbying group
January 11, 2011Research and Development, Sales and Marketing ABHI, ABPI, BIA, BIVDA, LifeSciencesUK, lobbying
Four industry trade associations including pharma body the ABPI have banded together to form a new lobbying group representing life …
UK pharma welcomes government reforms
November 30, 2010Manufacturing and Production, Research and Development, Sales and Marketing ABHI, ABPI, BIA, R&D tax credits, UK pharma, patent box
The UK pharma industry has responded warmly to government plans to review how best to create optimum conditions for private …
